FDA Clears Hospira Rocky Mt.

[Anonymous]

All you fools wasted thousands of hours on here ranting about FDA Hundreds of threads and hyper links about FDA and Now, look what happened FDA clears HSP and you look like FOOLS just as I predicted Give it up Slackers and get your lazy ass out looking for work

hr guy

 

[Anonymous]

Jive Fool wasted their life away posting about FDA It was all for nothing
And now they are quiet like the broken troll they are Who's your daddy ?

 

[Anonymous]

For now, give HSP six mos to screw things up again.

 

[Anonymous]

For now, give HSP six mos to screw things up again.

You may be right, but then the game will be played again and pockets greased
and the world spins and spins Relax it's all good

hr guy

 

[Anonymous]

All you fools wasted thousands of hours on here ranting about FDA Hundreds of threads and hyper links about FDA and Now, look what happened FDA clears HSP and you look like FOOLS just as I predicted Give it up Slackers and get your lazy ass out looking for work

hr guy

what about India it's not serious will be cleared

 

[Anonymous]

For now, give HSP six mos to screw things up again.

Stockholders / Brass are Laughing at YOU !

Hr Guy

 

[Anonymous]

unscrupulous managers leading employee blindly corporate iS lyin to worKers
we won't and cent take it no more

 

[Anonymous]

Hospira has been dealing with FDA concerns for years for plants in the U.S. and more recently in India. But despite being told more than a year ago that it should have a "global corrective action plan" for both its foreign and U.S. plants, new issues have surfaced, this time for a plant in Australia that makes specialty injectable drugs. As of October 15, 2014, Hospira is recalling "certain lots of several products in its LifeCare line of flexible intravenous solutions due to the potential for leakage." But the description does not get to the depth and breadth of the recall, which is for 54 lots of nearly a dozen products. That includes two dozen lots of saline solution in the 1000-mL size, an essential hospital product that has been in short supply for months.

 

[Anonymous]

Hospira has been dealing with FDA concerns for years for plants in the U.S. and more recently in India. But despite being told more than a year ago that it should have a "global corrective action plan" for both its foreign and U.S. plants, new issues have surfaced, this time for a plant in Australia that makes specialty injectable drugs. As of October 15, 2014, Hospira is recalling "certain lots of several products in its LifeCare line of flexible intravenous solutions due to the potential for leakage." But the description does not get to the depth and breadth of the recall, which is for 54 lots of nearly a dozen products. That includes two dozen lots of saline solution in the 1000-mL size, an essential hospital product that has been in short supply for months.

N U W SUCKS !! TONY RULES AND KICKS ASS !!!!!